Fiche centre
University of California San Francisco
San Francisco — United States
Essais liés24clinical trials
VilleSan Franciscolocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06211764
Essais cliniques associés
24| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ExAblate MRgFUS | Cancer | Non applicable | NCT01833806 | A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain | COMPLETED |
| NRTX-1001 | Épilepsie | Phase 3 | NCT05135091 | Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) | RECRUITING |
| Ocrelizumab | SEP | Phase 4 | NCT04998812 | MINORE — A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy | COMPLETED |
| Empagliflozin | Maladie rénale chronique | Phase 3 | NCT07107945 | A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) | ACTIVE_NOT_RECRUITING |
| Acoramidis | Alzheimer | Phase 2 | NCT03536767 | Open-Label Study of AG10 in Patients With Cardiomyopathy | TERMINATED |
| ATTN201 Focused Ultrasound to the CMN | Alzheimer | Non applicable | NCT07866768 | CMN LIFU for Enhanced Amyloid Reduction (CLEART Study) | RECRUITING |
| ExAblate 2100 | Cancer | Non applicable | NCT00981578 | ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain | TERMINATED |
| TAR-200 | Cancer | Phase 3 | NCT06211764 | SunRISe-5 — A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) | ACTIVE_NOT_RECRUITING |
| Medtronic Percept Deep Brain Stimulation (cDBS) | Parkinson | Non applicable | NCT07398157 | Subgaleal aDBS — Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease | RECRUITING |
| 18F-Flortaucipir radiopharmaceutical | Alzheimer | Phase 1 | NCT05361382 | Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| Prasinezumab | Parkinson | Phase 2 | NCT04777331 | PADOVA — A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease | ACTIVE_NOT_RECRUITING |
| Baricitinib 4 MG | Alzheimer | Phase 3 | NCT05858515 | REVERSE-LC — REVERSE-Long COVID-19 With Baricitinib Study | WITHDRAWN |
| Medtronic Percept Deep Brain Stimulation (adaptive DBS) | Parkinson | Non applicable | NCT07682311 | Auto aDBS — Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator | RECRUITING |
| FT819 | Lupus | Phase 2 | NCT07570862 | RECLAIM-LN — A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis | RECRUITING |
| Nerandomilast | Myopathies | Phase 3 | NCT07789015 | VERANDA™-IIM — A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | NOT_YET_RECRUITING |
| AIDP — Automated Imaging Differentiation of Parkinsonism | Parkinson | À vérifier | NCT05913687 | AIDP — Automated Imaging Differentiation of Parkinsonism | ACTIVE_NOT_RECRUITING |
| N-acetyl cysteine | SEP | Phase 2 | NCT02804594 | A Study of Oxidative Pathways in MS Fatigue | COMPLETED |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) | Sclérose latérale amyotrophique | À vérifier | NCT04363684 | ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) | RECRUITING |
| Amitriptyline | Migraine | Non applicable | NCT05889624 | Responding With Evidence and Access for Childhood Headaches | RECRUITING |
| Ocrelizumab | SEP | Phase 3 | NCT05269004 | OLERO — A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| Anti-hypertensive therapy | Hypertension | Phase 4 | NCT02299414 | Chronic Hypertension and Pregnancy (CHAP) Project | COMPLETED |
| Rifaximin | Parkinson | Phase 1 | NCT03575195 | MICRO-PD — Microbiota Intervention to Change the Response of Parkinson's Disease | SUSPENDED |
| Efgartigimod PH20 SC | Myasthénie | Phase 3 | NCT06558279 | ADAPT oculus — A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis | ACTIVE_NOT_RECRUITING |
| ONC201 | Cancer | À vérifier | NCT05392374 | Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas | NO_LONGER_AVAILABLE |